Vimarsana
Biggest News Aggregation in the World

Chembio Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Chembio Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Chembio Diagnostics Today - Breaking & Trending Today

CDC Laboratory Recommendations for Syphilis Testing, United States, 2024 - Vimarsana News

CDC Laboratory Recommendations for Syphilis Testing, United States, 2024

This report provides new CDC recommendations for tests that can support a diagnosis of syphilis.

Source: cdc.gov
ProciseDx Expands Intellectual Property Portfolio with Purchase of Two US Therapeutic Drug Monitoring Patents - Vimarsana News

ProciseDx Expands Intellectual Property Portfolio with Purchase of Two US Therapeutic Drug Monitoring Patents

/PRNewswire/ -- ProciseDx Inc. announces that it has purchased two US patents in therapeutic drug monitoring (TDM) of biologic drugs to supplement its existing...

Life Science Outsourcing, Inc. Welcomes Neil A. Goldman as Chief Financial Officer - Vimarsana News

Life Science Outsourcing, Inc. Welcomes Neil A. Goldman as Chief Financial Officer

BREA, Calif., Oct. 17, 2023 /PRNewswire/ -- Life Science Outsourcing, Inc. , a premier contract manufacturer and value-added service provider for the medical device and life science sectors,...

Qualigen Therapeutics Divests FastPack® Diagnostics Business - Vimarsana News

Qualigen Therapeutics Divests FastPack® Diagnostics Business

All cash deal with Chembio Diagnostics, a US Subsidiary of the French Diagnostics Company BIOSYNEX, SA, solidifies Qualigen’s strategic priority on therapeutics CARLSBAD, Calif., July 24, 2023...

Point of Care Diagnostics Market is Expected to Reach $75.5 billion | MarketsandMarkets. - Vimarsana News

Point of Care Diagnostics Market is Expected to Reach $75.5 billion | MarketsandMarkets.

The global point-of-care market is expected to reach $75.5 billion by 2027 from an estimated $45.4 billion in 2022, at a CAGR of 10.7% from 2022 to 2027.